Medicare Enrolled
Dr. Damanjit Ghuman, MD
Medical Oncology · Jersey City, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ghuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghuman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ghuman
Dr. Damanjit Ghuman is a medical oncology specialist in Jersey City, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ghuman performed 57,649 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ghuman received a total of $10,997 from 77 pharmaceutical and/or device companies across 632 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghuman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 12% volume in NJ
$10,997 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗57,649
Medicare services
Top 12% in NJ for medical oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
30,750 | $1 | $3 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
17,650 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
3,740 | $2 | $10 |
| Denosumab injection (Prolia/Xgeva) | 1,800 | $18 | $68 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
858 | $0 | $0 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
633 | $8 | $34 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
523 | $8 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $103 | $423 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
374 | $12 | $48 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
218 | $26 | $102 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
201 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
198 | $56 | $234 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $71 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
85 | $118 | $466 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
31 | $0 | $8 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $155 | $588 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
54.2% high complexity
42.7% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,997
Total received (2018-2024)
Avg $1,571/year across 7 years
Top 12% in NJ for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
632
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,777
2023
$775
2022
$1,742
2021
$2,108
2020
$1,363
2019
$1,548
2018
$1,684
Payments by company (2024)
Daiichi Sankyo Inc.
$206
Lilly USA, LLC
$175
GENZYME CORPORATION
$138
Janssen Biotech, Inc.
$132
Amgen Inc.
$122
Novartis Pharmaceuticals Corporation
$86
PharmaEssentia USA Corporation
$80
Bayer Healthcare Pharmaceuticals Inc.
$74
Takeda Pharmaceuticals U.S.A., Inc.
$72
TerSera Therapeutics LLC
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
PFIZER INC.
$63
SOBI, INC
$60
PUMA BIOTECHNOLOGY, INC.
$56
Merck Sharp & Dohme LLC
$54
Alexion Pharmaceuticals, Inc.
$49
ARRAY BIOPHARMA INC
$44
E.R. Squibb & Sons, L.L.C.
$44
Regeneron Healthcare Solutions, Inc.
$27
EMD Serono, Inc.
$26
Gilead Sciences, Inc.
$25
TAIHO ONCOLOGY, INC.
$24
Novocure Inc.
$24
Aveo Pharmaceuticals, Inc.
$22
Celgene Corporation
$15
Celltrion USA Inc.
$15
Stemline Therapeutics Inc.
$14
Top 3 companies account for 29.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$958
AstraZeneca Pharmaceuticals LP
$843
Janssen Biotech, Inc.
$752
Amgen Inc.
$636
E.R. Squibb & Sons, L.L.C.
$587
PFIZER INC.
$504
Daiichi Sankyo Inc.
$462
Seagen Inc.
$428
Merck Sharp & Dohme Corporation
$397
Celgene Corporation
$369
GENZYME CORPORATION
$311
Lilly USA, LLC
$303
Astellas Pharma US Inc
$291
Genentech USA, Inc.
$289
Exelixis Inc.
$283
Incyte Corporation
$234
Gilead Sciences, Inc.
$211
Pharmacyclics LLC, An AbbVie Company
$200
Takeda Pharmaceuticals U.S.A., Inc.
$144
Regeneron Healthcare Solutions, Inc.
$142
BeiGene USA, Inc.
$126
Karyopharm Therapeutics Inc.
$125
SANOFI-AVENTIS U.S. LLC
$115
Merck Sharp & Dohme LLC
$114
EISAI INC.
$107
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Ipsen Biopharmaceuticals, Inc
$100
Bayer Healthcare Pharmaceuticals Inc.
$94
PharmaEssentia USA Corporation
$80
Alexion Pharmaceuticals, Inc.
$80
Puma Biotechnology, Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$76
GE HealthCare
$75
ARRAY BIOPHARMA INC
$73
TerSera Therapeutics LLC
$65
GlaxoSmithKline, LLC.
$65
EMD Serono, Inc.
$65
Janssen Pharmaceuticals, Inc
$60
SOBI, INC
$60
Otsuka America Pharmaceutical, Inc.
$58
PUMA BIOTECHNOLOGY, INC.
$56
Teva Pharmaceuticals USA, Inc.
$54
Dova Pharmaceuticals
$53
Rigel Pharmaceuticals, Inc.
$46
Myovant Sciences Inc.
$45
Eisai Inc.
$42
Novocure Inc.
$41
Horizon Therapeutics plc
$40
Blueprint Medicines Corporation
$34
Seattle Genetics, Inc.
$28
Kyowa Kirin, Inc.
$27
TESARO, Inc.
$27
Sobi, Inc
$27
Kite Pharma, Inc.
$25
AVEO Pharmaceuticals, Inc.
$25
TAIHO ONCOLOGY, INC.
$24
Aveo Pharmaceuticals, Inc.
$22
ADC Therapeutics America, Inc.
$21
Myriad Genetic Laboratories, Inc.
$21
Mirati Therapeutics, Inc.
$18
Octapharma USA, Inc.
$18
Sumitomo Pharma America, Inc.
$18
Jazz Pharmaceuticals Inc.
$17
ABB Con-Cise Optical Group LLC
$17
MACROGENICS, INC.
$16
Organon LLC
$15
Epizyme, Inc.,
$15
JAZZ PHARMACEUTICALS INC.
$15
Celltrion USA Inc.
$15
CTI BioPharma Corp.
$15
Taiho Oncology, Inc.
$15
Acceleron Pharma, Inc.
$14
Global Blood Therapeutics, Inc.
$14
Stemline Therapeutics Inc.
$14
AbbVie Inc.
$13
AbbVie, Inc.
$13
Mylan Pharmaceuticals Inc.
$13
Top 3 companies account for 23.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aranesp · Avastin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · CABOMETYX · CALQUENCE · CHANTIX · CINQAIR · COSELA · CYRAMZA · Cabometyx · Columvi · Contact Lens · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · ENHERTU · ENTYVIO · ERLEADA · EVENITY · EXKIVITY · Enhertu · Erleada · FASLODEX · FOTIVDA · Fabhalta · Fulphila · GAVRETO · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Idhifa · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KISUNLA · KRAZATI · KRYSTEXXA · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MYLOTARG · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OMVOH · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · POTELIGEO · PROMACTA · Padcev · Perjeta · Quzyttir · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · SANCUSO · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TEPEZZA · TUKYSA · Tavalisse · Trodelvy · Truxima · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · ZEJULA · ZEPZELCA · ZYMFENTRA · ZYTIGA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
351
County median income
$90,032
Nearest hospital to ZIP centroid (approximate)
CAREPOINT HEALTH-CHRIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ghuman is a mixed practice specialist, with above-average Medicare volume (top 12% in NJ), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ghuman experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ghuman performed 30,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ghuman receive payments from pharmaceutical companies?
Yes. Dr. Ghuman received a total of $10,997 from 77 companies across 632 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ghuman's costs compare to other medical oncologists in Jersey City?
Dr. Ghuman's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ghuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Jersey City
Browse medical oncologists in Jersey City ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NJ
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NJ
Which NJ medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology